![Is personalized medicine worth the cost? [PODCAST]](https://i.ytimg.com/vi/g6lxUwrIxsY/hqdefault.jpg "Is personalized medicine worth the cost? [PODCAST]")
Is personalized medicine worth the cost? [PODCAST]
No Byline Policy Editorial Guidelines Corrections Policy Source
Read More
Pharmaceuticals
is the time ripe for investment?
According to GlobalData, investment in the Asia-Pacific (APAC) biotech sector is lagging behind its US Over the period 2018 to 2022, the APAC region received £23 billion ($29 billion) for the development of innovative early-stage drugs, whereas American biotech…
Read More
Zimbabwe shows interest in Belarus’ healthcare, pharmaceutical industry
Prior to this, Auxillia Mnangagwa toured the National Medical Center run by the Belarus President Property Management Directorate, as well as the National Research Center Mother and Child, the National Pediatric Rehabilitation Hospital in Ostroshitsky Gorodok, the Alexandrov National Cancer…
Read More
Big Pharma Versus the Capital Vices
What if you could cure mental illness by changing the chemistry of a patient’s brain? This was the motivating question for Arthur Sackler, patriarch of the Purdue Pharma dynasty, as posed in Patrick Radden Keefe’s 2021 tome Empire of
Read More
Indian Pharma industry expected to reach about 13% in global pharma market: Report
Performing as per its tag as the ‘pharmacy of the world’, India has been a global generic medicine supplier for over 200 countries from both developed and emerging As per the report, the country has attained recent traction for…
Read More
Industry Leader Tim Walbert Joins Mirum Pharmaceuticals’ Board of Directors
Mirum Pharmaceuticals, (Nasdaq: MIRM) today announced that Tim Walbert has been appointed to the company’s Board of In addition to Walbert’s appointment, the company shared that Niall O’Donnell, a Mirum director since November 2018, has announced…
Read More
MRK vs. BMY: Which Pharmaceutical Stock is Better?
Merck & (NYSE:MRK) What is the Price Target for MRK Stock? Bristol-Myers Squibb (NYSE:BMY) What is the Price Target for BMY Stock? Conclusion: Bullish on MRK, Neutral on BMY No Byline Policy Editorial Guidelines Corrections Policy Source
Read More
Culinary, PhRMA oppose bill to extend lower Medicare negotiated drug prices to all Nevadans
No Byline Policy Editorial Guidelines Corrections Policy Source
Read More
View: India’s drug industry needs a major overhaul
For a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory In the last six months alone, its generic cough syrups have killed dozens of children, its eye drops have…
Read More
Generics, Investments and Expenses & Expanding Pharmaceutical Industry Promises Market Growth
GlaxoSmithKline Novartis UK Limited Sun Pharmaceuticals UK Limited Johnson & Johnson Limited Perrigo Company Reckitt Benckiser AstraZeneca Cough, Cold, and Flu Vitamins, Mineral, and Supplements (VMS) Analgesics Gastrointestinal Products Dermatology Products Others Tablets Capsules Liquids &…
Read More